|
Volumn 8, Issue 3, 2002, Pages 161-166
|
Heart failure and implantable cardioverter defibrillator (ICD) therapy: Update and perspective on current primary prevention trials
|
Author keywords
Heart failure; ICD
|
Indexed keywords
AMIODARONE;
ANTIARRHYTHMIC AGENT;
ANTILIPEMIC AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
DIGITALIS;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
ADULT;
AGED;
CARDIOMYOPATHY;
CLINICAL TRIAL;
DEFIBRILLATOR;
FEMALE;
HEART FAILURE;
HEART LEFT VENTRICLE FAILURE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
PRIMARY PREVENTION;
PRIORITY JOURNAL;
REVIEW;
SUDDEN DEATH;
UNITED STATES;
ARTICLE;
CONGESTIVE CARDIOMYOPATHY;
CONGESTIVE HEART FAILURE;
HEART PACING;
MIDDLE AGED;
MORTALITY;
AGED;
CARDIAC PACING, ARTIFICIAL;
CARDIOMYOPATHY, DILATED;
CLINICAL TRIALS;
DEATH, SUDDEN, CARDIAC;
DEFIBRILLATORS, IMPLANTABLE;
FEMALE;
HEART FAILURE, CONGESTIVE;
HUMANS;
MALE;
MIDDLE AGED;
|
EID: 0036023206
PISSN: 10719164
EISSN: None
Source Type: Journal
DOI: 10.1054/jcaf.2002.125555 Document Type: Article |
Times cited : (2)
|
References (12)
|